Safety, Eligibility, and Provider Guidance for Retatrutide Access Retatrutide carries similar safety considerations to tirzepatide: gastrointestinal side effects, pancreatitis risk monitoring, and possible thyroid C-cell effects (animal data)
GLP-1 agonists handle appetite
If youre using a telehealth provider for your GLP-1 prescription, ask directly whether baseline labs are required or recommended before your first dose
Tuersun A, Hou G, Cheng G (2024) Efficacy and safety of the combination or monotherapy with GLP-1 receptor agonists and SGLT-2 inhibitors in Type 2 diabetes mellitus: an update systematic review and meta-analysis
The most frequently reported adverse events were primarily gastrointestinal-related and generally mild to moderate in severity
Your locked rate continues indefinitely for the entire duration of your subscription, providing unprecedented cost predictability in telehealth weight management